Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix

(Source: PharmiWeb.com) Safety data analyzed to date shows no significant difference in adverse event … In addition, we are continuing to investigate theapplication of INOpulse for the …